To Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy

• Status: Completed
• Trial end date: 2019-07-31
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effect of wound infiltration with 0.25% Bupivacaine in laparoscopic cholecystectomy in terms of pain severity, patient satisfaction level, quality of life, hospital stay and return to job and normal activities.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
• Treatments: Bupivacaine

Criteria

Inclusion criteria

• Patients scheduled to undergo laparoscopic cholecystectomy under general anesthesia at department of surgery and department of hepatobiliary system, BSMMU

• Patients who are eligible according to ASA Ⅰ -Ⅱ

• Female or male, age ≥18 years

• Patients who are scheduled for same anesthetic technique and surgical procedure for laparoscopic cholecystectomy

• Discharge of patient between 12 hour to 36 hour after performing procedure

• Patients given consent for enrollment in study

Exclusion criteria

• Patients known to be allergic to certain recommended drugs

• If patients have history of psychiatric illness

• Patients on chronic analgesic therapy for any other indication

• Patients who are scheduled for different anesthetic technique and surgical procedure for laparoscopic cholecystectomy

• Duration of surgery more than 1 hour

• Patients undergoing laparoscopic cholecystectomy for complex gallbladder disease such as incidental gallbladder pancreatitis, gallstone pancreatitis, cholecystoduodenal fistula, mirizzi syndrome

• Special population group such as children, pregnant woman, patients with cirrhosis, diabetics

• Duration of operative procedure more than 1 hour